TOLERACELL
Live / Allowed — Third extension granted (statement of use) (as of 29 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Mar 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97307429
- Mark type
- Word mark
- Filed
- 11 Mar 2022
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Stephen G. Anderson
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for medical use for regulating the immune system
Owner
- Diabetes Free, Inc, New York, NY, US
- Diabetes Free, Inc, New York, NY, US
Board proceedings on this mark
- Extension of Time to Oppose No. 97307429 — Fate Therapeutics, Inc. v. Diabetes Free, Inc, filed 08 Aug 2024 (Terminated)
Prosecution history
- 30 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2026 — SOU EXTENSION 3 GRANTED
- 29 Apr 2026 — SOU EXTENSION 3 FILED
- 29 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2025 — SOU EXTENSION 2 GRANTED
- 29 Oct 2025 — SOU EXTENSION 2 FILED
- 29 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2025 — SOU EXTENSION 1 GRANTED
- 28 Apr 2025 — SOU EXTENSION 1 FILED
- 28 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Sept 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 08 Aug 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED